Therefore, in this study, in order to explore the effectiveness of the use of cervical cancer therapeutic antibodies, after analyzing the influence of MLK4 on immune cell infiltration, the expression of MLK4, CTLA4, PD-L1 and other immune checkpoints was further explored, so as to provide a new molecular marker for cervical cancer immunotherapy. The gene discussed is CTLA4; the disease is cervical cancer.